Author

Pieter Jan de Jonge

ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS
ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS

Pieter Jan de Jonge  et al.

SCREENING FOR METACHRONOUS ESOPHAGEAL SECOND PRIMARY TUMORS IN PATIENTS WITH HEAD AND NECK CANCER
SCREENING FOR METACHRONOUS ESOPHAGEAL SECOND PRIMARY TUMORS IN PATIENTS WITH HEAD AND NECK CANCER

Pieter Jan de Jonge  et al.

DIAGNOSTIC YIELD OF GASTRIC BIOPSIES OF THE INCISURA IN PATIENTS WITH GASTRIC INTESTINAL METAPLASIA IN A LOW INCIDENCE GASTRIC CANCER REGION
DIAGNOSTIC YIELD OF GASTRIC BIOPSIES OF THE INCISURA IN PATIENTS WITH GASTRIC INTESTINAL METAPLASIA IN A LOW INCIDENCE GASTRIC CANCER REGION

Pieter Jan de Jonge  et al.

PANCREATOSCOPY-GUIDED ELECTROHYDRAULIC LITHOTRIPSY FOR THE TREATMENT OF OBSTRUCTIVE DISTAL MAIN PANCREATIC DUCT STONES; LONG-TERM OUTCOMES
PANCREATOSCOPY-GUIDED ELECTROHYDRAULIC LITHOTRIPSY FOR THE TREATMENT OF OBSTRUCTIVE DISTAL MAIN PANCREATIC DUCT STONES; LONG-TERM OUTCOMES

Pieter Jan de Jonge  et al.

RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?
RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?

Pieter Jan de Jonge  et al.

THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES
THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES

Pieter Jan de Jonge  et al.

HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS
HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Pieter Jan de Jonge  et al.

PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX
PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

Pieter Jan de Jonge  et al.

COLONIZATION OF THE GASTROINTESTINAL MICROBIOTA WITH ENTEROCOCCUS AND STAPHYLOCOCCUS PREDICTS INFECTION IN PATIENTS WITH NECROTIZING PANCREATITIS (POEMA): PROSPECTIVE MULTICENTER STUDY
COLONIZATION OF THE GASTROINTESTINAL MICROBIOTA WITH ENTEROCOCCUS AND STAPHYLOCOCCUS PREDICTS INFECTION IN PATIENTS WITH NECROTIZING PANCREATITIS (POEMA): PROSPECTIVE MULTICENTER STUDY

Pieter Jan de Jonge  et al.

RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS
RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS

Pieter Jan de Jonge  et al.

Item 1 - 10 / 10
1